insurance coverage glp-1 just changed for as many as 56 million Americans when it comes to the popular medications used to promote weight loss. Story🔗below GLP-1 Insurance Coverage Guide: Biomarkers

11% of American adults report taking the medications, up from just 3% in 2024, according to a Gallup poll

Novo Nordisk (Mojsov emails

By signaling immune cells to reduce excessive inflammatory responses, it helps prevent chronic tissue damage

doi: 10.1016/s0014-2999(99)00486-0

Compared to sulfonylureas and metformin, liraglutide demonstrates advantages in glycemic control (assessed by HbA1c levels) and reduction of liver fat content (LFC) in patients with MASLD and T2DM, with a more significant difference observed over sulfonylureas

Common Complaints: Some note delayed onset of effects (46 weeks), while others question effectiveness without injections